Literature DB >> 30238419

[Association of circulating tumor cell status with benefit of radiotherapy and survival in early-stage breast cancer].

Marciana Nona Duma1.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 30238419     DOI： 10.1007/s00066-018-1370-7

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN： 0179-7158            Impact factor:   3.621


× No keyword cloud information.
  11 in total

1.  Breast-conserving surgery with or without irradiation in women aged 65 years or older with early breast cancer (PRIME II): a randomised controlled trial.

Authors:  Ian H Kunkler; Linda J Williams; Wilma J L Jack; David A Cameron; J Michael Dixon
Journal:  Lancet Oncol       Date:  2015-01-28       Impact factor: 41.316

2.  70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer.

Authors:  Fatima Cardoso; Laura J van't Veer; Jan Bogaerts; Leen Slaets; Giuseppe Viale; Suzette Delaloge; Jean-Yves Pierga; Etienne Brain; Sylvain Causeret; Mauro DeLorenzi; Annuska M Glas; Vassilis Golfinopoulos; Theodora Goulioti; Susan Knox; Erika Matos; Bart Meulemans; Peter A Neijenhuis; Ulrike Nitz; Rodolfo Passalacqua; Peter Ravdin; Isabel T Rubio; Mahasti Saghatchian; Tineke J Smilde; Christos Sotiriou; Lisette Stork; Carolyn Straehle; Geraldine Thomas; Alastair M Thompson; Jacobus M van der Hoeven; Peter Vuylsteke; René Bernards; Konstantinos Tryfonidis; Emiel Rutgers; Martine Piccart
Journal:  N Engl J Med       Date:  2016-08-25       Impact factor: 91.245

3.  Radiotherapy or tamoxifen after conserving surgery for breast cancers of excellent prognosis: British Association of Surgical Oncology (BASO) II trial.

Authors:  R W Blamey; T Bates; U Chetty; S W Duffy; I O Ellis; D George; E Mallon; M J Mitchell; I Monypenny; D A L Morgan; R D Macmillan; J Patnick; S E Pinder
Journal:  Eur J Cancer       Date:  2013-03-21       Impact factor: 9.162

4.  Lumpectomy plus tamoxifen with or without irradiation in women age 70 years or older with early breast cancer: long-term follow-up of CALGB 9343.

Authors:  Kevin S Hughes; Lauren A Schnaper; Jennifer R Bellon; Constance T Cirrincione; Donald A Berry; Beryl McCormick; Hyman B Muss; Barbara L Smith; Clifford A Hudis; Eric P Winer; William C Wood
Journal:  J Clin Oncol       Date:  2013-05-20       Impact factor: 44.544

5.  Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer.

Authors:  Bernard Fisher; Stewart Anderson; John Bryant; Richard G Margolese; Melvin Deutsch; Edwin R Fisher; Jong-Hyeon Jeong; Norman Wolmark
Journal:  N Engl J Med       Date:  2002-10-17       Impact factor: 91.245

Review 6.  Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials.

Authors:  S Darby; P McGale; C Correa; C Taylor; R Arriagada; M Clarke; D Cutter; C Davies; M Ewertz; J Godwin; R Gray; L Pierce; T Whelan; Y Wang; R Peto
Journal:  Lancet       Date:  2011-10-19       Impact factor: 79.321

7.  Comparison of EndoPredict and EPclin With Oncotype DX Recurrence Score for Prediction of Risk of Distant Recurrence After Endocrine Therapy.

Authors:  Richard Buus; Ivana Sestak; Ralf Kronenwett; Carsten Denkert; Peter Dubsky; Kristin Krappmann; Marsel Scheer; Christoph Petry; Jack Cuzick; Mitch Dowsett
Journal:  J Natl Cancer Inst       Date:  2016-07-10       Impact factor: 13.506

8.  EndoPredict improves the prognostic classification derived from common clinical guidelines in ER-positive, HER2-negative early breast cancer.

Authors:  P Dubsky; M Filipits; R Jakesz; M Rudas; C F Singer; R Greil; O Dietze; I Luisser; E Klug; R Sedivy; M Bachner; D Mayr; M Schmidt; M C Gehrmann; C Petry; K E Weber; R Kronenwett; J C Brase; M Gnant
Journal:  Ann Oncol       Date:  2012-10-03       Impact factor: 32.976

9.  Circulating tumor cells predict survival in early average-to-high risk breast cancer patients.

Authors:  Brigitte Rack; Christian Schindlbeck; Julia Jückstock; Ulrich Andergassen; Philip Hepp; Thomas Zwingers; Thomas W P Friedl; Ralf Lorenz; Hans Tesch; Peter A Fasching; Tanja Fehm; Andreas Schneeweiss; Werner Lichtenegger; Matthias W Beckmann; Klaus Friese; Klaus Pantel; Wolfgang Janni
Journal:  J Natl Cancer Inst       Date:  2014-05-15       Impact factor: 13.506

10.  Clinical validation of the EndoPredict test in node-positive, chemotherapy-treated ER+/HER2- breast cancer patients: results from the GEICAM 9906 trial.

Authors:  Miguel Martin; Jan C Brase; Lourdes Calvo; Kristin Krappmann; Manuel Ruiz-Borrego; Karin Fisch; Amparo Ruiz; Karsten E Weber; Blanca Munarriz; Christoph Petry; Cesar A Rodriguez; Ralf Kronenwett; Carmen Crespo; Emilio Alba; Eva Carrasco; Maribel Casas; Rosalia Caballero; Alvaro Rodriguez-Lescure
Journal:  Breast Cancer Res       Date:  2014-04-12       Impact factor: 6.466
View more
  1 in total

1.  ATP6AP1 is a potential prognostic biomarker and is associated with iron metabolism in breast cancer.

Authors:  Ye Tian; Ming Gao; Liang Huang; Hu Zhou; Juan Wang
Journal:  Front Genet       Date:  2022-09-06       Impact factor: 4.772
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.